Parkinsonism & Related Disorders

Papers
(The H4-Index of Parkinsonism & Related Disorders is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study107
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?104
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents68
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors61
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia59
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia58
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease53
White matter connectivity networks predict early dementia conversion in Parkinson’s disease51
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS51
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease49
Chorea-Acanthocytosis: A Case Report49
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease49
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention46
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment44
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.43
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome41
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease41
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease41
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder39
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex38
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 202136
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease35
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease34
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit32
Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?32
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school32
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyse31
Effects of an intensive, multidisciplinary rehabilitative treatment in an outpatient setting on clinical outcomes in Parkinson’s Disease: preliminary results.30
Perry disease in an Argentine family due to the DCTN1 p.G67D variant30
Leveraging Telehealth and Wearables for Parkinson’s Disease: Innovative Approaches to Enhance Personalized Care29
0.092866897583008